Citra Buana Prasida Tbk. vs Merck Tbk. — how do they compare? Citra Buana Prasida Tbk. trades at Rp282 (market cap 385.18B, 10.2K 24h volume), while Merck Tbk. trades at Rp3,800 (market cap 1.68T, 33.3K 24h volume). The key difference: Merck Tbk. is far larger — about 4.4× Citra Buana Prasida Tbk.'s market cap, and Merck Tbk. is more actively traded (33.3K versus 10.2K). Which is the better fit depends on your goals.
| CBPE | MERK | |
|---|---|---|
Market Cap | 385.18B | 1.68T |
Volume | 10.2K | 33.3K |
Lot | 102 | 333 |
Turnover | 2.9M | 126.46M |
Average Price | 283.88 | 3,797.72 |
Value | 2.9M | 126.46M |
Indicative Equilibrium Price | — | 3,800 |
Indicative Equilibrium Volume | — | 9 |
Trailing returns across standard periods
Latest headlines on both assets
PT Citra Buana Prasida Tbk Entity which was originally named PT Prasetia Sejati was established on August 24, 2000 based on the Deed of Establishment No. 18, drawn up in the presence of Ninik Sukadarwati, SH., Notary of the Bekasi Regency Level II, in Tambun. The Entity started its commercial business in 2005.
Read more on CBPE →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →